SILKWAVE INC (00471): Tian Tian has been appointed as an executive director.
China Broadcasting Corporation (00471) announced that the board of directors declared, effective February 25, 2026:
SILKWAVE INC (00471) announced that the Board of Directors has declared, effective February 25, 2026:
(1) Ms. Hu Lanying has resigned as an executive director and Vice Chairman of the Board;
(2) Mr. Lin Changsheng has resigned as an independent non-executive director, Chairman of the Company's Remuneration Committee, and as a member of the Company's Audit Committee and Nomination Committee;
(3) Mr. Wong Qiuzhi has resigned as Chairman of the Board, CEO of the Company, and Chairman of the Nomination Committee, but will remain as an executive director;
(4) Mr. Zou Yifeng has been appointed as an executive director, Chairman, CEO, and Chairman of the Nomination Committee;
(5) Ms. Tian Tian has been appointed as an executive director;
(6) Mr. Lin Baoquan has been appointed as an independent non-executive director, Chairman of the Remuneration Committee, and as a member of the Audit Committee and Nomination Committee;
(7) Ms. Hu Manqiu has been reassigned from a non-executive director to an executive director.
Mr. Wong Qiuzhi has resigned as the authorized representative of the Company in accordance with Rule 3.05 of the Listing Rules and as the representative authorized to receive legal process documents in Hong Kong under Section 16 of the Company Ordinance (Chapter 622 of the Laws of Hong Kong), effective from February 25, 2026. Mr. Zou Yifeng has been appointed as the authorized representative and agent for legal process documents, effective from February 25, 2026.
Related Articles

JIUYUAN GENE (02566): JiKeQin's listing application has been accepted by the National Medical Products Administration.

Novo Nordisk A/S Sponsored ADR Class B (NVO.US) invests up to $2.1 billion in partnership with Vivtex, doubling down on the next generation of oral weight loss drugs.

Culturecom Holdings Limited (00343): Chen Shuwen resigns as an independent non-executive director.
JIUYUAN GENE (02566): JiKeQin's listing application has been accepted by the National Medical Products Administration.

Novo Nordisk A/S Sponsored ADR Class B (NVO.US) invests up to $2.1 billion in partnership with Vivtex, doubling down on the next generation of oral weight loss drugs.

Culturecom Holdings Limited (00343): Chen Shuwen resigns as an independent non-executive director.

RECOMMEND

Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026

Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026

AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026


